Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Asmita Banstola, Ph.D.

Title
Institution
Department
Address
Profile Picture

Biography
Keimyung University, South KoreaPh.D.02/2022Pharmacy
2020
Best Oral Presentation Award
2020
Best Oral Presentation Award
2021
Best Poster Presentation Award
2021
Best Thesis Award
2019
Best Oral Presentation Award

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Duwa R, Pokhrel RH, Banstola A, Pandit M, Shrestha P, Jeong JH, Chang JH, Yook S. T-cell engaging poly(lactic-co-glycolic acid) nanoparticles as a modular platform to induce a potent cytotoxic immunogenic response against PD-L1 overexpressing cancer. Biomaterials. 2022 Dec; 291:121911. PMID: 36399833.
    Citations:    Fields:    Translation:HumansAnimalsCells
  2. Shrestha S, Banstola A, Jeong JH, Seo JH, Yook S. Targeting Cancer Stem Cells: Therapeutic and diagnostic strategies by the virtue of nanoparticles. J Control Release. 2022 08; 348:518-536. PMID: 35709876.
    Citations: 1     Fields:    Translation:HumansCells
  3. Banstola A, Poudel K, Kim JO, Jeong JH, Yook S. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death. J Control Release. 2021 09 10; 337:505-520. PMID: 34314800.
    Citations: 8     Fields:    Translation:Humans
  4. Banstola A, Poudel K, Pathak S, Shrestha P, Kim JO, Jeong JH, Yook S. Hypoxia-Mediated ROS Amplification Triggers Mitochondria-Mediated Apoptotic Cell Death via PD-L1/ROS-Responsive, Dual-Targeted, Drug-Laden Thioketal Nanoparticles. ACS Appl Mater Interfaces. 2021 May 19; 13(19):22955-22969. PMID: 33969998.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  5. Poudel K, Banstola A, Gautam M, Soe ZC, Pham LM, Jeong JH, Choi HG, Ku SK, Yong CS, Tran TH, Kim JO. Redox/photo dual-responsive, self-targeted, and photosensitizer-laden bismuth sulfide nanourchins for combination therapy in cancer. Nanoscale. 2021 Jan 21; 13(2):1231-1247. PMID: 33406178.
    Citations: 8     Fields:    Translation:HumansCells
  6. Banstola A, Poudel K, Emami F, Ku SK, Jeong JH, Kim JO, Yook S. Localized therapy using anti-PD-L1 anchored and NIR-responsive hollow gold nanoshell (HGNS) loaded with doxorubicin (DOX) for the treatment of locally advanced melanoma. Nanomedicine. 2021 04; 33:102349. PMID: 33359414.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  7. Poudel K, Banstola A, Gautam M, Soe Z, Phung CD, Pham LM, Jeong JH, Choi HG, Ku SK, Tran TH, Yong CS, Kim JO. Macrophage-Membrane-Camouflaged Disintegrable and Excretable Nanoconstruct for Deep Tumor Penetration. ACS Appl Mater Interfaces. 2020 Dec 23; 12(51):56767-56781. PMID: 33289550.
    Citations: 8     Fields:    Translation:AnimalsCells
  8. Banstola A, Duwa R, Emami F, Jeong JH, Yook S. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-co-glycolic acid) Nanoparticles in Epidermal Growth Factor Receptor Overexpressing Glioblastoma Cells. Mol Pharm. 2020 11 02; 17(11):4386-4400. PMID: 33079558.
    Citations: 4     Fields:    Translation:HumansCells
  9. Banstola A, Jeong JH, Yook S. Immunoadjuvants for cancer immunotherapy: A review of recent developments. Acta Biomater. 2020 09 15; 114:16-30. PMID: 32777293.
    Citations: 18     Fields:    Translation:Humans
  10. Poudel K, Banstola A, Tran TH, Thapa RK, Gautam M, Ou W, Pham LM, Maharjan S, Jeong JH, Ku SK, Choi HG, Yong CS, Kim JO. Hyaluronic acid wreathed, trio-stimuli receptive and on-demand triggerable nanoconstruct for anchored combinatorial cancer therapy. Carbohydr Polym. 2020 Dec 01; 249:116815. PMID: 32933663.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  11. Banstola A, Pham TT, Jeong JH, Yook S. Polydopamine-tailored paclitaxel-loaded polymeric microspheres with adhered NIR-controllable gold nanoparticles for chemo-phototherapy of pancreatic cancer. Drug Deliv. 2019 Dec; 26(1):629-640. PMID: 31237149.
    Citations: 9     Fields:    Translation:HumansCells
  12. Emami F, Banstola A, Vatanara A, Lee S, Kim JO, Jeong JH, Yook S. Doxorubicin and Anti-PD-L1 Antibody Conjugated Gold Nanoparticles for Colorectal Cancer Photochemotherapy. Mol Pharm. 2019 03 04; 16(3):1184-1199. PMID: 30698975.
    Citations: 35     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Banstola's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (1)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.